000 00589nam a2200109Ia 4500
008 230817s9999 xx 000 0 und d
100 _aAndrew Davies et al
245 0 _aSubcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org/sites/default/files/2023-08/subcutaneous_rituximab_for_the_treatment_of_b-cell_hematologic_malignancies_a_review_of_the_scientific_rationale_and_clinical_development.pdf
942 _cEBK
999 _c40622
_d40622